Literature DB >> 21268005

Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.

Masashi Iwasaki1, Yoshimasa Tanaka, Hirohito Kobayashi, Kaoru Murata-Hirai, Hideto Miyabe, Tomoharu Sugie, Masakazu Toi, Nagahiro Minato.   

Abstract

Programmed cell death-1 (PD-1) is an inhibitory receptor and plays an important role in the regulation of αβ T cells. Little is known, however, about the role of PD-1 in γδ T cells. In this study, we investigated the expression and function of PD-1 in human γδ T cells. Expression of PD-1 was rapidly induced in primary γδ T cells following antigenic stimulation, and the PD-1(+) γδ T cells produced IL-2. When PD-1(+) γδ T cells were stimulated with Daudi cells with and without programmed cell death ligand-1 (PD-L1) expression, the levels of IFN-γ production and cytotoxicity in response to PD-L1(+) Daudi cells were diminished compared to the levels seen in response to PD-L1(-) Daudi cells. The attenuated effector functions were reversed by anti-PD-L1 mAb. When PD-1(+) γδ T cells were challenged by PD-L1(+) tumors pretreated with zoledronate (Zol), which induced γδ TCR-mediated signaling, the resulting reduction in cytokine production was only slight to moderate compared to the reduction seen when PD-1(+) γδ T cells were challenged by PD-L1(-) tumors. In addition, cytotoxic activity of PD-1(+) γδ T cells against Zol-treated PD-L1(+) tumors was comparable to that against Zol-treated PD-L1(-) tumors. These results suggest that TCR triggering may partially overcome the inhibitory effect of PD-1 in γδ T cells.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21268005     DOI: 10.1002/eji.201040959

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  65 in total

1.  Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.

Authors:  Tomohiro Okagawa; Satoru Konnai; James R Deringer; Massaro W Ueti; Glen A Scoles; Shiro Murata; Kazuhiko Ohashi; Wendy C Brown
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

2.  Synthesis and Immunomodulatory Activity of Fluorine-Containing Bisphosphonates.

Authors:  Satoshi Mizuta; Mohammed S O Tagod; Masashi Iwasaki; Yoichi Nakamura; Hiroaki Senju; Hiroshi Mukae; Craig T Morita; Yoshimasa Tanaka
Journal:  ChemMedChem       Date:  2019-01-25       Impact factor: 3.466

3.  Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.

Authors:  Kilian Wistuba-Hamprecht; Alexander Martens; Karin Haehnel; Marnix Geukes Foppen; Jianda Yuan; Michael A Postow; Phillip Wong; Emanuela Romano; Amir Khammari; Brigitte Dreno; Mariaelena Capone; Paolo A Ascierto; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Anis Larbi; Bastian Schilling; Dirk Schadendorf; Jedd D Wolchok; Christian U Blank; Graham Pawelec; Claus Garbe; Benjamin Weide
Journal:  Eur J Cancer       Date:  2016-07-09       Impact factor: 9.162

4.  Prolonged PD1 Expression on Neonatal Vδ2 Lymphocytes Dampens Proinflammatory Responses: Role of Epigenetic Regulation.

Authors:  Haoting Hsu; Sarah Boudova; Godfrey Mvula; Titus H Divala; Randy G Mungwira; Christopher Harman; Miriam K Laufer; C David Pauza; Cristiana Cairo
Journal:  J Immunol       Date:  2016-07-29       Impact factor: 5.422

5.  Ex vivo expanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer.

Authors:  Dang Wu; Pin Wu; Xianguo Wu; Jun Ye; Zhen Wang; Shuai Zhao; Chao Ni; Guoming Hu; Jinghong Xu; Yuehua Han; Ting Zhang; Fuming Qiu; Jun Yan; Jian Huang
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 6.  Harnessing the power of Vδ2 cells in cancer immunotherapy.

Authors:  D W Fowler; M D Bodman-Smith
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

7.  Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.

Authors:  Cédric Rossi; Pauline Gravelle; Emilie Decaup; Julie Bordenave; Mary Poupot; Marie Tosolini; Don-Marc Franchini; Camille Laurent; Renaud Morin; Jean-Michel Lagarde; Loïc Ysebaert; Laetitia Ligat; Christine Jean; Ariel Savina; Christian Klein; Alba Matas Céspedes; Patricia Perez-Galan; Jean-Jacques Fournié; Christine Bezombes
Journal:  Oncoimmunology       Date:  2018-12-17       Impact factor: 8.110

8.  Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.

Authors:  Tomoharu Sugie; Kaoru Murata-Hirai; Masashi Iwasaki; Craig T Morita; Wen Li; Haruki Okamura; Nagahiro Minato; Masakazu Toi; Yoshimasa Tanaka
Journal:  Cancer Immunol Immunother       Date:  2012-11-15       Impact factor: 6.968

9.  PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance.

Authors:  Alessandra Dondero; Fabio Pastorino; Mariella Della Chiesa; Maria Valeria Corrias; Fabio Morandi; Vito Pistoia; Daniel Olive; Francesca Bellora; Franco Locatelli; Aurora Castellano; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Oncoimmunology       Date:  2015-07-15       Impact factor: 8.110

10.  Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation.

Authors:  Oumar Attaher; Irfan Zaidi; Jennifer L Kwan; Djibrilla Issiaka; Mamoudou B Samassekou; Kadidia B Cisse; Barou Coulibaly; Sekouba Keita; Sibiri Sissoko; Tiangoua Traore; Kalifa Diarra; Bacary S Diarra; Adama Dembele; Moussa B Kanoute; Almahamoudou Mahamar; Amadou Barry; Michal Fried; Alassane Dicko; Patrick E Duffy
Journal:  J Infect Dis       Date:  2020-01-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.